Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Serrano-Candelas

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
International Journal of Molecular Sciences|December 11, 2025
Identification and Characterization of ERK2 Dimerization Inhibitors by Integrated In Silico and In Vitro ScreeningCarmen Ortiz-González, Berta Casar, Rafael Gozalbes, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 27, 2015
The adaptor 3BP2 is required for KIT receptor expression and human mast cell survivalErola Ainsua-Enrich, Eva Serrano-Candelas, Damiana Álvarez-Errico, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 29, 2017
Correction: The Adaptor 3BP2 Is Required for KIT Receptor Expression and Human Mast Cell SurvivalErola Ainsua-Enrich, Eva Serrano-Candelas, Damiana Álvarez-Errico, et al.
Journal of Cheminformatics|November 6, 2024
Quantitative structure-activity relationships of chemical bioactivity toward proteins associated with molecular initiating events of organ-specific toxicityDomenico Gadaleta, Marina Garcia de Lomana, Eva Serrano-Candelas, et al.
International Journal of Molecular Sciences|June 19, 2024
Comparative Binding Study of Gliptins to Bacterial DPP4-like Enzymes for the Treatment of Type 2 Diabetes Mellitus (T2DM)Laureano E Carpio, Marta Olivares, Alfonso Benítez-Paez, et al.
International Journal of Molecular Sciences|October 26, 2024
Computational Strategies for Assessing Adverse Outcome Pathways: Hepatic Steatosis as a Case StudyRita Ortega-Vallbona, Martina Palomino-Schätzlein, Laia Tolosa, et al.
Toxins|June 27, 2023
MicotoXilico: An Interactive Database to Predict Mutagenicity, Genotoxicity, and Carcinogenicity of MycotoxinsJosefa Tolosa, Eva Serrano Candelas, José Luis Vallés Pardo, et al.
Toxicology|March 1, 2024
Uncovering the toxicity mechanisms of a series of carboxylic acids in liver cells through computational and experimental approachesRita Ortega-Vallbona, Rebeca Méndez, Laia Tolosa, et al.
NAM Journal|June 30, 2026
GenoITS: Implementation of an Integrated Testing Strategy workflow for genotoxicity using QSAR-based toolsJosé Luis Vallés-Pardo, Eva Serrano-Candelas, Addel Goya-Jorge, et al.
Molecular Therapy. Oncology|May 9, 2025
Preclinical study of microphthalmia-associated transcription factor inhibitor ML329 in gastrointestinal stromal tumor growthMario Guerrero, Elizabeth Proaño-Pérez, Eva Serrano-Candelas, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
International Journal of Molecular Sciences|December 11, 2025
Identification and Characterization of ERK2 Dimerization Inhibitors by Integrated In Silico and In Vitro ScreeningCarmen Ortiz-González, Berta Casar, Rafael Gozalbes, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 27, 2015
The adaptor 3BP2 is required for KIT receptor expression and human mast cell survivalErola Ainsua-Enrich, Eva Serrano-Candelas, Damiana Álvarez-Errico, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 29, 2017
Correction: The Adaptor 3BP2 Is Required for KIT Receptor Expression and Human Mast Cell SurvivalErola Ainsua-Enrich, Eva Serrano-Candelas, Damiana Álvarez-Errico, et al.
Journal of Cheminformatics|November 6, 2024
Quantitative structure-activity relationships of chemical bioactivity toward proteins associated with molecular initiating events of organ-specific toxicityDomenico Gadaleta, Marina Garcia de Lomana, Eva Serrano-Candelas, et al.
International Journal of Molecular Sciences|June 19, 2024
Comparative Binding Study of Gliptins to Bacterial DPP4-like Enzymes for the Treatment of Type 2 Diabetes Mellitus (T2DM)Laureano E Carpio, Marta Olivares, Alfonso Benítez-Paez, et al.
International Journal of Molecular Sciences|October 26, 2024
Computational Strategies for Assessing Adverse Outcome Pathways: Hepatic Steatosis as a Case StudyRita Ortega-Vallbona, Martina Palomino-Schätzlein, Laia Tolosa, et al.
Toxins|June 27, 2023
MicotoXilico: An Interactive Database to Predict Mutagenicity, Genotoxicity, and Carcinogenicity of MycotoxinsJosefa Tolosa, Eva Serrano Candelas, José Luis Vallés Pardo, et al.
Toxicology|March 1, 2024
Uncovering the toxicity mechanisms of a series of carboxylic acids in liver cells through computational and experimental approachesRita Ortega-Vallbona, Rebeca Méndez, Laia Tolosa, et al.
NAM Journal|June 30, 2026
GenoITS: Implementation of an Integrated Testing Strategy workflow for genotoxicity using QSAR-based toolsJosé Luis Vallés-Pardo, Eva Serrano-Candelas, Addel Goya-Jorge, et al.
Molecular Therapy. Oncology|May 9, 2025
Preclinical study of microphthalmia-associated transcription factor inhibitor ML329 in gastrointestinal stromal tumor growthMario Guerrero, Elizabeth Proaño-Pérez, Eva Serrano-Candelas, et al.
Pageof 5